Anzeige
Mehr »
Login
Samstag, 18.01.2025 Börsentäglich über 12.000 News von 682 internationalen Medien
Letzte Chance, bevor die Bohrer dieses "Monster"-Vorkommen bei einem 13-Millionen-Unternehmen ansteuern
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
356 Leser
Artikel bewerten:
(2)

ConMet Marks 60 Years of Innovation and Industry Leadership

Finanznachrichten News

VANCOUVER, WA / ACCESSWIRE / March 29, 2024 / ConMet, a trusted partner in the commercial vehicle industry, is proud to kick off a celebration of its 60th anniversary. For six decades, ConMet has been at the forefront of innovation, creating numerous groundbreaking products that have revolutionized the industry. As the company looks to the future, it remains committed to driving the industry forward with its relentless pursuit of innovation and excellence.

ConMet Celebrates 60 Years

Since its inception on March 30, 1964, as a subsidiary of Consolidated Freightways, ConMet has consistently delivered forward-thinking solutions to the commercial vehicle industry. The company has introduced a wide range of products that have set new standards for performance, efficiency, and reliability.

One of ConMet's key contributions to the industry has been its PreSet® and PreSet Plus® wheel hub assemblies, which have helped eliminate premature wheel end failure on heavy-duty trucks and trailers. These advanced hub systems, along with other cutting-edge products such as interior and exterior plastics, aluminum castings, eHub, and IoT solutions, have propelled ConMet to the forefront of the industry.

With over 37 million PreSet and PreSet Plus hubs globally having traveled approximately 22 trillion miles on the road, ConMet has established itself as a trusted partner to OEMs. The company's wheel hubs are the preferred choice for all North American heavy-duty truck manufacturers, several Chinese commercial vehicle manufacturers, and many trailer manufacturers. Its commitment to delivering class-leading service and support further solidifies its position as a reliable industry supplier.

Throughout its 60-year journey, ConMet has achieved numerous significant milestones. From establishing its first aluminum foundry in 1964 to launching its eMobility business unit in 2020, the company's commitment to excellence and continuous improvement has propelled its success. ConMet has also expanded its operations globally, with operations in Mexico, China and Europe, further strengthening its presence in the global market.

Looking ahead, ConMet is poised to continue its legacy of innovation. The recent acquisition of TruckWings is a testament to the company's dedication to developing solutions to save fleets money and cut carbon emissions. Additionally, ConMet is expanding its eMobility business with the acquisition of in-wheel motor technology from Saietta Group's Netherlands branch.

The company is also actively working on the next generation of its Nmotion energy regeneration system for trailers, which powers electric transport refrigeration units and contributes to the industry's transition towards zero-emission vehicles.

As ConMet celebrates its 60th anniversary, it remains committed to its core values of innovation, quality, and collaboration. The company's dedicated employees, from engineering to manufacturing, play a vital role in driving the industry forward. Together, they strive to deliver best-in-class components that exceed customer expectations and contribute to the advancement of the commercial vehicle industry.

For more information about ConMet's 60th anniversary celebration and achievements, please visit conmet.com/sixty-years.

Contact Information

David Brierley
Media Relations Manager
marketing@conmet.com
360 409 6570

SOURCE: ConMet

.

View the original press release on newswire.com.

© 2024 ACCESS Newswire
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.